EDVANYSEBeveragesFiscal year ends December 31

Endovia Health Sciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.14−0.01 (-7.53%)

Close on Oct 19, 2026

Market cap: $413.76K
P/E (TTM): –
Dividend yield: –

Endovia Health Sciences, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Cash & Equivalents	0.28	0.02	0.17	4.43	4.18	0.38	0.04	0.94	0.02	0.06	0.01	0.02	0.00	0.01	0.01	0.05
Cash & Short-Term Investments	0.28	0.02	0.17	4.43	4.18	0.38	0.04	0.94	0.02	0.06	0.01	0.02	0.00	0.01	0.01	0.05
Receivables	0.02	0.19	0.89	1.81	1.11	0.48	0.01	0.30	0.15	0.21	0.17	0.08	0.06	0.01	0.02	–
Inventory	0.03	0.32	2.25	3.72	1.92	0.80	0.30	0.04	–	–	–	–	–	–	–	–
Prepaid Expenses & Other	0.21	0.27	0.22	0.35	0.61	0.17	0.01	–	–	–	–	–	–	–	–	–
Total Current Assets	0.63	1.90	3.98	11	8.34	2.24	0.37	0.35	0.19	0.29	0.20	0.12	0.07	0.02	0.02	–
Property, Plant & Equipment	0.01	0.02	0.35	0.49	0.57	0.68	0.04	0.06	0.05	0.06	0.04	0.05	0.02	–	–	–
Gross Property, Plant & Equipment	0.05	0.05	2.18	2.16	2.12	2.08	0.09	0.15	0.14	0.14	0.08	0.00	0.00	–	–	–
Accumulated Depreciation	-0.04	-0.03	-1.83	-1.67	-1.55	-1.40	-0.05	-0.09	-0.09	-0.08	-0.04	-0.02	-0.02	–	–	–
Operating Lease Right-of-Use Assets	0.05	0.35	0.56	0.75	1.03	0.08	0.16	0	–	–	–	–	–	–	–	–
Goodwill	–	–	0.26	0.26	0.26	5.67	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	4.46	4.85	5.60	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	–	0.12	0.15	0.22	–	–	–	–	–	–	–
Total Assets	0.97	2.76	9.90	17	16	9.23	0.61	0.41	0.24	0.36	0.24	0.17	0.10	0.02	0.02	–
Accounts Payable	4.81	3.59	4.44	3.38	1.91	1.52	0.70	0.33	0.23	0.21	0.14	0.07	0.04	0.02	0.03	–
Short-Term Debt	–	–	–	–	–	–	0.00	0.01	0.01	0.01	-0.01	–	–	–	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	0.00	0.01	0.01	0.01	0.01	0.01	0.00	–	–	–
Current Debt	–	–	–	–	–	–	0.01	0.02	0.02	0.02	0	0.01	0.00	–	–	–
Current Portion of Leases	0.05	0.06	0.26	0.27	0.29	0.06	0.08	0	–	–	–	–	–	–	–	–
Total Current Liabilities	16	19	15	4.97	6.48	5.42	10	0.41	0.30	0.29	0.22	0.16	0.14	0.11	0.12	–
Long-Term Debt	0.00	1.97	0.46	2.54	0.30	1.24	0.00	0.01	0.01	0.03	0.02	0.03	0.02	–	–	–
Long-Term Leases	0.00	0.05	0.30	0.48	0.73	0.03	0.08	0	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.05	0.36	0.56	0.75	1.03	0.08	0.02	0	–	–	–	–	–	–	–	–
Total Liabilities	16	21	16	7.98	7.51	9.33	10	0.41	0.31	0.32	0.24	0.19	0.16	0.11	0.12	–
Total Debt	0.00	1.97	0.46	2.54	0.30	1.24	0.01	0.02	0.04	0.05	0.02	0.04	0.02	–	–	–
Preferred Stock	–	0	0	0	0	–	0	0	0	0	–	–	–	–	–	–
Common Stock	0.00	0.00	0.00	0.04	0.03	0.02	0.04	0.25	0.24	0.21	0.12	0.12	0	0	0	–
Additional Paid-In Capital	167	137	128	122	99	52	22	0	–	–	–	–	–	–	–	–
Retained Earnings	-182	-156	-133	-112	-91	-62	-32	-0.25	-0.32	-0.17	-0.12	-0.14	-0.11	-0.11	-0.09	–
Treasury Stock	–	–	–	–	–	–	-0.05	–	–	–	–	–	–	–	–	–
Comprehensive Income & Other	0.03	0.08	-0.02	-0.02	0	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	-15	-19	-5.61	9.32	8.87	-9.35	-9.76	-7.83	-0.07	0.04	0.00	-0.02	-0.06	-0.09	-0.09	-0.04
Total Equity	-15	-19	-5.61	9.32	8.87	-9.35	-9.76	-7.83	-0.07	0.04	0.00	-0.02	-0.06	-0.09	-0.09	-0.04
Total Liabilities & Equity	0.97	2.76	9.90	17	16	9.23	0.61	0.41	0.24	0.36	0.24	0.17	0.10	0.02	0.02	–
Shares Outstanding(shares)	0.75	0.42	0.28	0.26	0.21	0.13	0.27	0.23	0.23	0.22	0.20	0.20	0.20	0.19	0.16	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 34.7%
Operating margin: -18486.6%
Net margin: -23653.4%
Return on equity, FY2025: 148.7%

Financial strength

Current ratio: 0.05
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 1.4%

Valuation

P/E ratio: –
Price to sales: 5.66
Price to book: –
Dividend yield: –